We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

129 hedge funds and large institutions have $312M invested in Viking Therapeutics in 2022 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more call options, than puts

Call options by funds: $22.8M | Put options by funds: $5.27M

330% more capital invested

Capital invested by funds: $72.4M → $312M (+$239M)

135% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 17

21% more funds holding

Funds holding: 107 → 129 (+22)

9.79% more ownership

Funds ownership: 34.71% → 44.5% (+9.8%)

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

Holders
129
Holders Change
+22
Holders Change %
+20.56%
% of All Funds
2.07%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
40
Increased
34
Reduced
34
Closed
17
Calls
$22.8M
Puts
$5.27M
Net Calls
+$17.5M
Net Calls Change
+$17.1M

Top Buyers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
+$6.7M
2
GPP
Great Point Partners
Connecticut
+$5.78M
3
Millennium Management
Millennium Management
New York
+$5.71M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.94M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.18M

Top Sellers

Rank Fund Capital Flow
1
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$11.5M
2
Marshall Wace
Marshall Wace
United Kingdom
-$5.66M
3
Walleye Capital
Walleye Capital
New York
-$3.95M
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$1.32M
5
IC
Ikarian Capital
Texas
-$1.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
AAA
26
Affinity Asset Advisors
New York
$3.29M +$446K +100,000 +40%
CSS
27
Cubist Systematic Strategies
Connecticut
$3.27M +$256K +57,245 +20%
Macquarie Group
28
Macquarie Group
Australia
$3.1M – – –
GTC
29
Ghost Tree Capital
New York
$2.82M +$1.34M +300,000 New
Invesco
30
Invesco
Georgia
$2.43M +$1.15M +258,322 New
State Street
31
State Street
Massachusetts
$2.32M – – –
Deutsche Bank
32
Deutsche Bank
Germany
$2.26M – – –
GCP
33
GSA Capital Partners
United Kingdom
$2.03M -$26K -5,832 -3%
Walleye Capital
34
Walleye Capital
New York
$2.01M -$3.95M -885,019 -81%
EGI
35
EAM Global Investors
California
$1.99M +$943K +211,228 New
IC
36
Ikarian Capital
Texas
$1.91M -$1.16M -260,000 -56%
MAP
37
Moody Aldrich Partners
Massachusetts
$1.91M +$906K +202,919 New
Bank of New York Mellon
38
Bank of New York Mellon
New York
$1.49M +$242K +54,142 +52%
Osaic Holdings
39
Osaic Holdings
Arizona
$1.39M +$6.54K +1,466 +1%
CC
40
Cornerstone Capital
California
$1.31M -$20.6K -4,625 -3%
SSA
41
Schonfeld Strategic Advisors
New York
$1.27M +$254K +56,924 +73%
AGP
42
Artia Global Partners
Florida
$1.23M +$584K +130,913 New
RJFSA
43
Raymond James Financial Services Advisors
Florida
$1.21M -$64.7K -14,500 -10%
Citigroup
44
Citigroup
New York
$1.21M +$548K +122,781 +2,262%
Northern Trust
45
Northern Trust
Illinois
$1.19M -$62 -14 -0%
TI
46
Trexquant Investment
Connecticut
$1.04M +$493K +110,414 New
Balyasny Asset Management
47
Balyasny Asset Management
Illinois
$975K -$11.5M -2,569,794 -96%
MCM
48
Moore Capital Management
New York
$940K +$446K +100,000 New
Bank of America
49
Bank of America
North Carolina
$911K -$93.2K -20,880 -18%
RJA
50
Raymond James & Associates
Florida
$882K -$48.5K -10,861 -10%
1
2
3 4 5

VKTX Hedge Fund Activity: Q4 2022 in Review

129 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q4 2022, worth a combined $312M — up 330% from $72.4M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new VKTX positions and 17 closed out — a net gain of 23 holders — while 34 added to existing stakes and 34 trimmed.

The largest buyer was Boxer Capital, opening a new position worth an estimated $6.7M. The largest seller was Balyasny Asset Management, cutting an estimated $11.5M.

  • 129 institutional investors held Viking Therapeutics (VKTX) as of Q4 2022, up from 107 in Q3 2022.
  • Funds reported $312M of Viking Therapeutics stock for Q4 2022, up 330% quarter-over-quarter.
  • 40 funds opened new Viking Therapeutics positions in Q4 2022 and 17 closed out, a net change of +23 holders.
  • The largest Viking Therapeutics buyer in Q4 2022 was Boxer Capital, an estimated $6.7M added.
  • The largest Viking Therapeutics seller in Q4 2022 was Balyasny Asset Management, an estimated $11.5M sold.

Based on aggregated 13F filings for Q4 2022.